Skip to content

TO SEE THE EFFICACY OF HOMOEOPATHIC MEDICINE LACHESIS MUTUS IN PRE-MENOPAUSAL SYNDROME

EFFICACY OF LACHESIS IN CASES OF PRE MENOPAUSAL SYNDROME - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099752
Enrollment
30
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: LACHESIS MUTUS: 6C /30C/200C/1M OD/BD/TDS THE POTENCY AND REPETITION OF LACHESIS MUTUS WIll BE SELECTED DEPENDING UPON THE SUSCEPTIBILITY OF THE PATIENT Control Intervention1: NIL: NIL

Sponsors

DR KOMAL RAVAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: WOMEN 40-55 YEARS WITH PREMENOPAUSAL/PRE-MENOPAUSAL STATUS (IRREGULAR CYCLES IN LAST 12 MONTHS BUT NOT AMENORRHEIC FOR 12 MONTHS) MODERATE TO SEVERE CLIMACTERIC SYMPTOMS WILLING TO AVOID STARTING HRT/OTHER NEW THERAPIES DURING STUDY

Exclusion criteria

Exclusion criteria: SEVERE PSYCHIATRIC ILLNESS, UNCONTROLLED THYROID DISEASE, UNCONTROLLED DM/HTN, ACTIVE MALIGNANCY PREGNANCY/LACTATION, HYPERSENSITIVITY TO ALCOHOL/ SUGAR GLOBULES

Design outcomes

Primary

MeasureTime frame
Menopause Rating Scale (MRS): A widely used, validated, self-administered scale with 11 items divided into three subscales: somatic (e.g., hot flashes, sleep problems), psychological (e.g., depressive mood, anxiety), and urogenital (e.g., sexual problems, vaginal dryness). Scores help categorize symptom severity from no/little to severe.Timepoint: AT BASELINE AND AT THE END OF THE TREATMENT AA PER REQUIREMENT OF THE CASE

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDR NANDINI S BARVE

BARODA HOMEOPATHIC MEDICAL COLLEGE AND HOSPITAL

nandinisk23@gmail.com9998216445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026